Ex2IA2 Flashcards

1
Q

Characteristics of Isoflurane

A

Halogenated methyl ethyl ether
Clear, nonflammable at room temp
Pungent, ethereal odor
Intermediate solubility, high potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Isoflurane has a ______ onset and recovery from anesthesia

A

Rapid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

T/F isoflurane contains thymol

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Intermediates of isoflurane

A

Acyl halide - hepatic necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sevoflurane characteristics

A

Fully fluorinated - methyl isopropyl ether
Nonpungent, minimal odor
Least degree of airway irritation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Preferred agent for inhalation induction

A

Sevoflurane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sevoflurane has a _____ induction/emergence

A

Rapid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sevoflurane metabolism

A

3-5% undergoes biodegradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sevoflurane metabolites

A

Inorganic fluoride (nephrotoxic)
Hexafluoroisopropanol (ulcerations to mucus membrane/skin)
No acyl halide metabolites (liver toxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Least likely to form CO on exposure to CO2 absorbants

A

Sevo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Formed in presence of CO2 absorbents (Sevo)

A

Compound A (renal proximal tubular injury)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which agent has flow rate requirements?

A

Sevo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Flow rate requirements for Sevo

A

During 1st 2 MAC hours: flow must equal or > 1L/min

After 2 MAC hours: flows must be 2L/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Risk of low flows

A

High temperature of absorbant assoc. with canister explosions (esp 100% O2/N20 on ped pts Monday morning)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fluorination results in

A

Increased vapor pressure
Enhances molecular stability
Decreases potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which agents are fully fluorinated?

A

Sevo, Des

Only 2 Hydrogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Desflurane characteristics

A

Fluorinated methyl ethyl ether

Very pungent/irritating to lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which agent is not preferred for inhalation induction

A

Desflurane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does desflurane differ from iso

A

Substitution of F for Cl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Agent that produces most CO

A

Desflurane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Des metabolism

A

Minimal serum/urinary trifluoroacetate concentrations

Hepatic necrosis rare but possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Desflurane potency

A

1/5 of Iso

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Unique aspect of desflurane

A

High vapor pressure (boil at room temp)

Requires special vaporizer to regulate concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Sudden initiation of high concentrations of ______ may cause _______

A

Des
Tachycardia/coughing
**fentanyl 1.5-3mcg/kg can attenuate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What permits rapid onset/prompt awakening in ______
Solubility/potency | Desflurane
26
How is Nitrous administered during general anesthesia
Admin in combo with opioids/VAs
27
Characteristics of N2O
LMW, inorganic Sweet smelling/odorless Non-flammable, low potency, poorly soluble; supports combustion
28
N2O metabolism
Minimal - via gut reductive processes
29
Which IA produces analgesia
N2O
30
AEs of N2O
Skeletal muscle rigidity PONV Expansion of gas filled spaces Inactivation of VitB12
31
PTX volume can double in _____ with _____% N2O
10 minutes | 75%
32
Magnitude of volume expansion from N2O is influenced by
Partial pressure of N2O Blood flow to gas filled spaces Duration of administration
33
Which operations should you avoid N2O in?
Bowel obstruction Tympanic rupture Intraocular (retinal artery/vision loss)
34
Effect on CNS - CBF, CMRO2
Increased CBF (VAs > N2O) Decreased CMRO2 N2O increases CMRO2
35
How is increased ICP offset?
Hyperventilation paCO2 < 30 torr
36
Desflurane 0.5 MAC results in _____ ICP
No effect on ICP until >1.1 MAC
37
EEG at < 0.4 MAC
Increases in voltage/frequency produced
38
EEG 0.4 MAC
Amnesia occurs | CMRO2 begins to decrease
39
EEG 1 MAC
Decreased frequency | Max voltage achieved
40
ISO produces _____ at ____ MAC and _____ at 2 MAC
Burst suppression at 1.5 MAC | Isoelectric EEG at 2 MAC
41
Which IA has anticonvulsant properties?
ISO
42
N2O < 0.75 MAC can produce
Clonus/opisthotonus
43
N2O effect on evoked potentials
Decreases amplitude
44
What may effect anesthetic requirement
Surgical stimulation may increase requirement
45
``` Effect of IAs on CVS: direct myocardial ______ _______ of sympathetic outflow Peripheral autonomic ganglion _______ ______ Carotid sinus reflex activity _______ cAMP ________ catecholamine release ________ calcium influx via slow channels ```
direct myocardial ___depression___ ____inhibition___ of sympathetic outflow Peripheral autonomic ganglion ___blockade____ ___attenuated___ Carotid sinus reflex activity ____decreased___ cAMP ___ decreased_____ catecholamine release ____ decreased____ calcium influx via slow channels
46
Effect of IAs on CSF
Iso improves rate of absorption
47
Nitrous effect on CVS
Mild sympathomimetic stimulation - masks the cardiac depressant effects - mydriasis - increased body temp - increased catecholamine release - increased RAP - diaphoresis - vasoconstriction
48
How would IAs effect patients with HTN/anxiety?
Larger decrease in MAP
49
IA effect on MAP
Dose-dependent decrease | Offset during surgical stimulation
50
How do IAs effect MAP?
Primarily via reductions in SVR
51
N2O effect on MAP
Increase or no effect
52
IAs effect on HR
ISO/Sevo/Des increase HR - elderly less likely - Sevo at >1.5MAC
53
IA effect on HR
Des produces significant increases in HR if concentration increased suddenly *attenuated by prior small dose of opioid N2O depresses carotid sinus - may dampen HR response to hypotension
54
IA effect on CO
N/A only Sevo @ 1.5-2 MAC decreases
55
VA effect on SV
Decrease by 15-30%
56
Effect of N2O on CO
Modestly increased CO - d/t sympathomimetic effect - cardiac depression offset by sympathomimetic effect
57
IA effect on RAP
Increase (Sevo does NOT) N2O - d/t increased PVR (don’t use in pHTN)
58
IAs effect on SVR
Decrease N2O does not change - may produce constriction of cutaneous vessels (increased body temp) Iso - Beta agonist; heat loss
59
IAs effect on PulmVR
Little or no effect | N2O - increases (R—>L shunting may jeopardize oxygenation in pts with congenital heart defects)
60
Effect on HPV
Inhibited at greater than 1 MAC
61
Effect on dysrhthmias
Iso slows SA discharge - prolongs ventricular conduction times
62
Effect on rhythm
Prolong QTc
63
Which IA is acceptable for ablative procedures?
Sevo
64
Which IA should not be used in ablative studies?
Iso - increases the refractory period of accessory pathways/slows AV conduction
65
Effect on Coronary blood flow
All produce coronary dilation | *Iso preferentially dilates small resistance vessels more than larger conductance vessels
66
Anesthetic preconditioning
Brief exposure to VAs confers cardioprotection | Brief periods of myocardial ischemia prior to a longer period of ischemia provides protection
67
Abrupt increases in Iso/Des can result in?
Increase sympathetic/RAA activity Cause transient increase in SBP/HR/coughing **doses from 0.55-1.66 MAC *des>iso
68
Factors that effect transfer of IA from arterial blood to brain
Brain-blood partition coefficient CBF A-vD difference